Consistent with previously reported data, we observed that serum OPN levels were significantly higher in patients with malignant ovarian tumors than in those with benign tumors and healthy controls, with some malignant cases reaching values above 50,000 pg/mL. The gene discussed is SPP1; the disease is ovarian cancer.